X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (128) 128
index medicus (70) 70
female (63) 63
male (63) 63
oncology (58) 58
adult (54) 54
middle aged (54) 54
aged (49) 49
hematology (48) 48
aged, 80 and over (23) 23
article (23) 23
cancer (23) 23
treatment outcome (23) 23
t-cell lymphoma (22) 22
animals (21) 21
chronic lymphocytic-leukemia (20) 20
lymphomas (20) 20
expression (19) 19
lymphoma (18) 18
skin neoplasms - pathology (18) 18
dermatology (17) 17
rituximab (17) 17
antineoplastic combined chemotherapy protocols - therapeutic use (16) 16
mycosis fungoides (16) 16
neoplasm staging (16) 16
abridged index medicus (15) 15
antineoplastic agents - therapeutic use (15) 15
mice (15) 15
hemic and lymphatic diseases (14) 14
survival (14) 14
transplantation (14) 14
leukemia (13) 13
mycosis-fungoides (13) 13
pathology (13) 13
t cells (13) 13
care and treatment (12) 12
immunohistochemistry (12) 12
prognosis (12) 12
b-cell lymphoma (11) 11
follicular lymphoma (11) 11
hematology, oncology and palliative medicine (11) 11
lymphoma, t-cell, cutaneous - pathology (11) 11
mantle cell lymphoma (11) 11
non-hodgkins-lymphoma (11) 11
phase-ii trial (11) 11
sézary syndrome (11) 11
cutaneous t-cell lymphoma (10) 10
diagnosis (10) 10
lymphoma, non-hodgkin - therapy (10) 10
non-hodgkin's lymphomas (10) 10
research (10) 10
sezary syndrome (10) 10
sezary-syndrome (10) 10
therapy (10) 10
disease-free survival (9) 9
lymphoma, non-hodgkin - diagnosis (9) 9
lymphoma, non-hodgkin - drug therapy (9) 9
antibodies, monoclonal - administration & dosage (8) 8
antibodies, monoclonal - therapeutic use (8) 8
antibodies, monoclonal, murine-derived (8) 8
antineoplastic agents - administration & dosage (8) 8
bortezomib (8) 8
cell biology (8) 8
ebv (8) 8
gene expression regulation, neoplastic (8) 8
herpesvirus 4, human - genetics (8) 8
lymphoma, t-cell, cutaneous - drug therapy (8) 8
marginal zone lymphoma (8) 8
patients (8) 8
retrospective studies (8) 8
acute lymphoblastic-leukemia (7) 7
acute myeloid-leukemia (7) 7
antigens, cd - metabolism (7) 7
apoptosis (7) 7
cells, cultured (7) 7
chemotherapy (7) 7
combined modality therapy (7) 7
diffuse large b-cell lymphoma (7) 7
epstein-barr virus infections - complications (7) 7
health aspects (7) 7
in situ hybridization (7) 7
lymphoma, b-cell - pathology (7) 7
lymphoma, t-cell, cutaneous - genetics (7) 7
monoclonal antibodies (7) 7
mycosis fungoides - pathology (7) 7
phase-ii (7) 7
recurrence (7) 7
sezary syndrome - pathology (7) 7
skin neoplasms - metabolism (7) 7
survival analysis (7) 7
survival rate (7) 7
activation (6) 6
analysis (6) 6
bone-marrow-transplantation (6) 6
classification (6) 6
disease (6) 6
epidemiology (6) 6
epstein-barr-virus (6) 6
herpesvirus 4, human - isolation & purification (6) 6
histone deacetylase inhibitors - therapeutic use (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 10/2019
The development of Brentuximab vedotin has opened a new era in the management of PTCL. The improved outcomes with BV-CHP versus CHOP in the ECHELON-2 trial are... 
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10094, pp. 533 - 534
The discovery that CD30 (Ki-1, TNFRSF8), a membrane protein belonging to the tumour necrosis factor receptor superfamily, is uniformly expressed in anaplastic... 
Internal Medicine | CD30 | MEDICINE, GENERAL & INTERNAL | PAPULOSIS | BRENTUXIMAB VEDOTIN | PHASE-II | HODGKIN LYMPHOMA | LYMPHOPROLIFERATIVE DISORDERS | SGN-30 | Disorders | Clinical trials | Monoclonal antibodies | Lymphomas | Lymphocytes T | Fungal infections | Anaplastic large-cell lymphoma | Lymphoma | Patients | T-cell lymphoma | Pharmaceuticals
Journal Article
Oncology Times, ISSN 0276-2234, 10/2018, Volume 40, Issue 20, pp. 1 - 17
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4766 - 4766
Introduction: Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common types of cutaneous T-cell lymphoma (CTCL). Incidence rates for CTCL are... 
Journal Article
Frontiers in oncology, ISSN 2234-943X, 2017, Volume 7, p. 309
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 18, pp. 1681 - 1690
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2019, Volume 119, pp. S2 - S3
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2019, Volume 119, pp. S2 - S3
Journal Article
Blood, ISSN 0006-4971, 09/2017, Volume 130, Issue 12, pp. 1389 - 1390
Over the past 3 years, a veritable explosion of genomic data has begun to shed much needed light on the mutational landscape of cutaneous T-cell lymphoma... 
T-CELL LYMPHOMA | MUTATIONS | HEMATOLOGY | LANDSCAPE | PATHWAY | Chromosome Mapping | Lymphoma, T-Cell, Cutaneous - genetics | Genomics | Humans | Skin Neoplasms
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 12/2017, Volume 7, p. 309
Murine models serve as an effective way to mimic the in vivo tumor microenvironmental interactions that take place in patients with leukemias and lymphomas.... 
Cytokines/chemokines | Murine models | Lymphoma | Leukemia | Tumor cell plasticity | leukemia | cytokines/chemokines | ONCOLOGY | murine models | lymphoma | tumor cell plasticity | Usage | Equipment and supplies | Research | Animal models in research | Oncology, Experimental | Cancer
Journal Article
Journal Article
by Kim, Ellen J and Kim, Youn H and Bagot, Martine and Pinter-Brown, Lauren and Rook, Alain H and Porcu, Pierluigi and Horwitz, Steven M and Whittaker, Sean and Tokura, Yoshiki and Vermeer, Maarten and Zinzani, Pier Luigi and Sokol, Lubomir and Morris, Stephen and Ortiz-Romero, Pablo L and Eradat, Herbert and Scarisbrick, Julia and Tsianakas, Athanasios and Elmets, Craig and Dalle, Stephane and Fisher, David C and Halwani, Ahmad and Poligone, Brian and Greer, John and Fierro, Maria Teresa and Khot, Amit and Moskowitz, Alison J and Musiek, Amy and Shustov, Andrei and Pro, Barbara and Geskin, Larisa J and Dwyer, Karen and Moriya, Junji and Leoni, Mollie and Humphrey, Jeffrey S and Hudgens, Stacie and Grebennik, Dmitri O and Tobinai, Kensei and Duvic, Madeleine and Abhyankar, Sunil and Akilov, Oleg and Alpdogan, Onder and Beylot-Barry, Marie and Boh, Erin and Caballero, Dolores and Cowan, Richard and Dreno, Brigitte and Dummer, Reinhard and Fenske, Timothy and Foss, Francine and Fukuhara, Noriko and Giri, Pratyush and Habe, Koji and Hamada, Toshihisa and Hatake, Kiyohiko and Iida, Shinsuke and Ishikawa, Osamu and Iversen, Lars and Kiyohara, Eiji and Koga, Hiroshi and Korman, Neil and Kuss, Bryone Jean and Lamar, Zanetta and Lansigan, Frederick and Lechowicz, Mary Jo and Lerner, Adam and Magnolo, Nina and Mark, Lawrence and Miyagaki, Tomomitsu and Munoz, Javier and Nicolay, Jan Peter and Nishiwaki, Kaoru and Okamoto, Hiroyuki and Ohtsuka, Mikio and Pacheco, Theresa and Querfeld, Christiane and Rapini, Ronald Peter and Sano, Shigetoshi and Tanaka, Maiko and Tharp, Michael D and Uehara, Jiro and Wada, Hidefumi and Wells, Jillian and Wilcox, Ryan A and William, Basem and Yonekura, Kentaro and MAVORIC Investigators
The Lancet Oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1192 - 1204
Journal Article
Haematologica, ISSN 0390-6078, 05/2012, Volume 97, Issue 5, pp. 758 - 765
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2011, Volume 155, Issue 2, pp. 150 - 166
Summary Cutaneous T‐cell lymphomas (CTCL) are a heterogeneous group of malignancies derived from skin‐homing T cells. The most common forms of CTCL are Mycosis... 
cutaneous T‐cell lymphoma | cytokines | Sezary syndrome | interleukin 15 | mycosis fungoides | Mycosis fungoides | Cytokines | Interleukin 15 | Cutaneous T-cell lymphoma | Immunologic Surveillance | Mycosis Fungoides - immunology | Immunotherapy - methods | Clinical Trials as Topic - statistics & numerical data | Genes, Neoplasm | Humans | Antibodies, Monoclonal - therapeutic use | Sezary Syndrome - epidemiology | Mycosis Fungoides - epidemiology | Mycosis Fungoides - therapy | Cell Differentiation | Antigens, Neoplasm - analysis | Mycosis Fungoides - genetics | Sezary Syndrome - immunology | Multicenter Studies as Topic - statistics & numerical data | Cytokines - metabolism | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Biomarkers, Tumor - analysis | Hematopoietic Stem Cell Transplantation | Mycosis Fungoides - etiology | Skin Neoplasms - epidemiology | Disease Progression | Sezary Syndrome - etiology | Animals | T-Lymphocyte Subsets - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Transformation, Neoplastic | Sezary Syndrome - therapy | T-Lymphocyte Subsets - metabolism | Skin Neoplasms - genetics | Chromosome Aberrations | Histone Deacetylase Inhibitors - therapeutic use | Mice | Skin Neoplasms - etiology | Sezary Syndrome - genetics | Immunologic Factors - therapeutic use | PEGYLATED LIPOSOMAL DOXORUBICIN | DENILEUKIN DIFTITOX | HISTONE DEACETYLASE INHIBITOR | INTERNATIONAL-SOCIETY | SUBEROYLANILIDE HYDROXAMIC ACID | cutaneous T-cell lymphoma | PHASE-II | MONOCLONAL-ANTIBODY | DOSE INTERFERON-ALPHA | GENE-EXPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | HEMATOLOGY | Antimitotic agents | Care and treatment | Genetic research | Mycoses | Genetics | Non-Hodgkin's lymphomas | Gene expression | T cells | Antineoplastic agents | Cancer | Histone deacetylase | Genetic markers | biomarkers | Immunopathogenesis | Lymphocytes T | Malignancy | Skin | Epidemiology | T-cell lymphoma
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2019, Volume 9, p. 636
Journal Article